Clinical Trial Update: Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3 [NA]

View source ↗

Summary

An update on a study aiming to develop and validate a sputum mRNA biomarker panel to aid in the diagnostic work-up of asthma; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Asthmatic Patients | NA | Status: TERMINATED